Widening the neuroimaging features of adenosine deaminase 2 deficiency

23Citations
Citations of this article
22Readers
Mendeley users who have this article in their library.

Abstract

SUMMARY: Adenosine deaminase 2 deficiency (OMIM #615688) is an autosomal recessive disorder characterized by a wide clinical spectrum, including small- and medium-sized vessel vasculopathies, but data focusing on the associated neuroimaging features are still scarce in the literature. Here, we describe the clinical neuroimaging features of 12 patients with genetically proven adenosine deaminase 2 deficiency (6 males; median age at disease onset, 1.3 years; median age at genetic diagnosis, 15.5 years). Our findings expand the neuroimaging phenotype of this condition demonstrating, in addition to multiple, recurrent brain lacunar ischemic and/or hemorrhagic strokes, spinal infarcts, and intracranial aneurysms, also cerebral microbleeds and a peculiar, likely inflammatory, perivascular tissue in the basal and peripontine cisterns. Together with early clinical onset, positive family history, inflammatory flares and systemic abnormalities, these findings should raise the suspicion of adenosine deaminase 2 deficiency, thus prompting genetic evaluation and institution of tumor necrosis factor inhibitors, with a potential great impact on neurologic outcome.

Cite

CITATION STYLE

APA

Geraldo, A. F., Caorsi, R., Tortora, D., Gandolfo, C., Ammendola, R., Alessio, M., … Severino, M. (2021). Widening the neuroimaging features of adenosine deaminase 2 deficiency. In American Journal of Neuroradiology (Vol. 42, pp. 975–979). American Society of Neuroradiology. https://doi.org/10.3174/AJNR.A7019

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free